RxDoctor Payments DataLook up a doctor →

Norma Davis, NP

Adult Health · Yonkers, NYNPI 1538570619

Payments from drug & device makers

$25,287in general payments, 2019–2025

Across 1,258 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Amgen$2K
  • AstraZeneca$1K
  • GSK$1K
  • Astellas Pharma US Inc$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • plus $14K from 54 others

What the payments were for

  • Food & beverage$25,13599%
  • Education$1531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)261$4,301
Amgen(2 entities)83$1,589
AstraZeneca70$1,416
GSK59$1,353
Astellas Pharma US Inc48$1,219
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC67$1,192
Boehringer Ingelheim49$1,024
Teva Pharmaceuticals USA, Inc.58$976
Sanofi50$954
Otsuka America Pharmaceutical, Inc.43$923
Lundbeck LLC28$738
Sanofi-aventis U.S. LLC27$695
Novartis39$631
Abbott24$564
Lilly USA, LLC25$511
Nestle Healthcare Nutrition Inc.25$493
Novo Nordisk20$441
Esperion Therapeutics, Inc.18$424
Ironwood Pharmaceuticals, Inc17$404
CMP Pharma, Inc.8$378
Amarin Pharma, Inc.28$373
Aimmune Therapeutics, Inc.13$347
Merck16$335
Regeneron Healthcare Solutions, Inc.12$297
Ardelyx, Inc.12$289
Exact Sciences12$241
Bayer11$240
Sumitomo Pharma America, Inc.13$240
Mylan Specialty L.p.10$238
Shield Therapeutics Inc4$178
Biohaven Pharmaceuticals, Inc.8$147
Antares Pharma, Inc.7$142
Cequr Corporation4$139
Viatris Specialty LLC6$131
Takeda Pharmaceuticals U.S.A., Inc.5$126
Pfizer6$124
Biohaven Pharmaceutical Holding Company Ltd.6$116
Endo Pharmaceuticals Inc.5$109
Alkermes, Inc.4$106
Kowa Pharmaceuticals America, Inc.6$106
Johnson & Johnson6$103
Vanda Pharmaceuticals Inc.6$100
Actelion Pharmaceuticals US, Inc.3$86
Idorsia Pharmaceuticals US Inc4$81
Avanir Pharmaceuticals, Inc.4$81
Harmony Biosciences LLC3$79
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$70
Paratek Pharmaceuticals, Inc.3$64
Lexicon Pharmaceuticals, Inc.2$52
Axsome Therapeutics, Inc.2$41
Halozyme Inc2$39
Myriad Women's Health, Inc.2$35
Azurity Pharmaceuticals, Inc.2$33
Daiichi Sankyo Inc.1$29
Phathom Pharmaceuticals, Inc.1$23
Almirall LLC1$23
Corcept Therapeutics1$21
Biogen1$18
Almatica Pharma LLC1$16
Phadia US Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,287 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$197,310
Medicare patients
276
Services billed
2,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$96,775
OtezlaApremilast23$94,517
LinzessLinaclotide111$90,909
Metformin Hcl133$85,460
FarxigaDapagliflozin Propanediol94$67,610
JanuviaSitagliptin Phosphate169$66,959
Trelegy ElliptaFluticasone/Umeclidin/Vilanter91$63,061
RexultiBrexpiprazole81$60,507
Breztri AerosphereBudesonide/Glycopyr/Formoterol96$59,964
MounjaroTirzepatide51$57,345
Dermacinrx LidocanLidocaine29$56,342
Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate26$54,031
JardianceEmpagliflozin83$52,436
EliquisApixaban89$49,153
VascepaIcosapent Ethyl96$43,567

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere$1,416$132,790202 claims
AbbVieLinzess, Vraylar, Lumigan$4,301$130,822152 claims
Novo NordiskOzempic, Rybelsus$441$109,887107 claims
AmgenOtezla$1,589$94,51723 claims
MerckJanuvia, Janumet$335$84,718183 claims
Lilly USA, LLCMounjaro, Trulicity$511$74,71567 claims
GSKTrelegy Ellipta, Breo Ellipta$1,353$69,481106 claims
Otsuka America Pharmaceutical, Inc.Rexulti$923$60,50781 claims
Boehringer IngelheimJardiance$1,024$52,43683 claims
PfizerEliquis$124$49,15389 claims
Johnson & JohnsonXarelto, Invokamet$103$25,16558 claims
BayerKerendia$240$23,21828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.

Other adult health in Yonkers

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →